M. Maruszczak

Statistics

Publications

Citations

105

H-Index

Active since

2015

Affiliations

Costello Medical Consulting (United Kingdom)(Current)

Novartis (United Kingdom)

M. Maruszczak is an author at Costello Medical Consulting (United Kingdom) specializing in cost-effectiveness modeling, pharmacoeconomics, and pharmacy.

Publications per year

2015–2022

Publications

The who-choice cost-effectiveness Threshold: a Country-level analysis of changes over time

Mark D. Griffiths, M. Maruszczak, J. Kusel · Value in Health · 2015 · 38 citations

Pharmacy, Economics, Pharmacoeconomics +11

Cost-utility of fingolimod compared with dimethyl fumarate in highly active relapsing-remitting multiple sclerosis (RRMS) in England

M. Maruszczak, Stephen Montgomery, Matthew Griffiths et al. · Journal of Medical Economics · 2015 · 29 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

A discrete event simulation to model the cost-utility of fingolimod and natalizumab in rapidly evolving severe relapsing-remitting multiple sclerosis in the UK

Stephen Montgomery, M. Maruszczak, David Slater et al. · Journal of Medical Economics · 2016 · 20 citations

Pharmacy, Pharmacoeconomics, Cost-effectiveness Analysis +16

Estimating the Impact of Delayed Access to Oncology Drugs on Patient Outcomes in Canada

Jackie Vanderpuye-Orgle, Daniel Erim, Yi Qian et al. · Oncology and Therapy · 2022 · 18 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

1–4 of 4